Diagnostic efficacy of ([Ca]×[Cl])/P combined with ALP in the diagnosis and subtype differentiation of primary hyperparathyroidism - Top-Institutions - MDSpire

Diagnostic efficacy of ([Ca]×[Cl])/P combined with ALP in the diagnosis and subtype differentiation of primary hyperparathyroidism

  • By

  • Jingxian Zhao

  • Wei Chen

  • Jianping Lao

  • Donglian Wang

  • Tong Sun

  • June 5, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Taizhou Enze Medical Center
    Taizhou Enze Medical Center

    Taizhou, Zhejiang

    Key Differentiators

    • Endocrinology

  • #2

    Tokai Central Hospital of the Mutual Aid Association of Public School Teachers
    Tokai Central Hospital of the Mutual Aid Association of Public School Teachers

    Tokai, Aichi

    Key Differentiators

    • Endocrinology

  • #3

    Lund University Hospital
    Lund University Hospital

    Lund, Skåne

    Key Differentiators

    • Endocrinology

  • #4

    Ghent University Hospital
    Ghent University Hospital

    Ghent, East Flanders

    Key Differentiators

    • Endocrinology

  • #5

    Copenhagen General Population Study
    Copenhagen General Population Study

    Copenhagen, Capital Region

    Key Differentiators

    • Endocrinology

Original Source(s)

Diagnostic efficacy of ([Ca]×[Cl])/P combined with ALP in the diagnosis and subtype differentiation of primary hyperparathyroidism

  • by Jingxian Zhao, Wei Chen, Jianping Lao, Donglian Wang, Tong Sun

  • June 5, 2026

Related Content

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

Effects of dapagliflozin on myocardial motion parameters and cardiac electrophysiology in patients with type 2 diabetes Mellitus and coronary heart disease

Association of 25(OH)D status with calcium metabolism, inflammation, and thyroid autoimmunity in patients with type 2 diabetes mellitus